Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Harrison

Showing results (911-920 of 972) with videos related to

Pageof 98
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 21, 2019
Targeting PD-L1 Initiates Effective Antitumor Immunity in a Murine Model of Cushing DiseaseHanna R Kemeny, Aladine A Elsamadicy, S Harrison Farber, et al.
Nature Reviews. Microbiology|March 30, 2022
Tackling the emerging threat of antifungal resistance to human healthMatthew C Fisher, Ana Alastruey-Izquierdo, Judith Berman, et al.
Reproductive Health|December 18, 2020
Association of parity with birthweight and neonatal death in five sites: The Global Network's Maternal Newborn Health Registry studyAna Garces, Wilton Perez, Margo S Harrison, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 1, 2019
Addition of Flucytosine to Fluconazole for the Treatment of Cryptococcal Meningitis in Africa: A Multicountry Cost-effectiveness AnalysisTinevimbo Shiri, Angela Loyse, Lawrence Mwenge, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 1, 2010
Bronchodilator activity of (3R)-3-[[[(3-fluorophenyl)[(3,4,5-trifluorophenyl)methyl]amino] carbonyl]oxy]-1-[2-oxo-2-(2-thienyl)ethyl]-1-azoniabicyclo[2.2.2]octane bromide (CHF5407), a potent, long-acting, and selective muscarinic M3 receptor antagonistG Villetti, F Pastore, M Bergamaschi, et al.
Trials|June 18, 2015
AMBITION-cm: intermittent high dose AmBisome on a high dose fluconazole backbone for cryptococcal meningitis induction therapy in sub-Saharan Africa: study protocol for a randomized controlled trialMooketsi Molefi, Awilly A Chofle, Síle F Molloy, et al.
Plos Biology|December 11, 2020
In silico APC/C substrate discovery reveals cell cycle-dependent degradation of UHRF1 and other chromatin regulatorsJennifer L Franks, Raquel C Martinez-Chacin, Xianxi Wang, et al.
The Journal of Antimicrobial Chemotherapy|November 21, 2022
Population pharmacokinetics of liposomal amphotericin B in adults with HIV-associated cryptococcal meningoencephalitisKatharine E Stott, Melanie Moyo, Ajisa Ahmadu, et al.
Reproductive Health|December 18, 2020
Cesarean birth in the Global Network for Women's and Children's Health Research: trends in utilization, risk factors, and subgroups with high cesarean birth ratesMargo S Harrison, Ana L Garces, Shivaprasad S Goudar, et al.
American Journal of Perinatology|April 3, 2018
Stillbirth, Inflammatory Markers, and Obesity: Results from the Stillbirth Collaborative Research NetworkMargo S Harrison, Vanessa R Thorsten, Donald J Dudley, et al.
Pageof 98

Showing results (911-920 of 972) with videos related to

Sort By:
Pageof 98
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 21, 2019
Targeting PD-L1 Initiates Effective Antitumor Immunity in a Murine Model of Cushing DiseaseHanna R Kemeny, Aladine A Elsamadicy, S Harrison Farber, et al.
Nature Reviews. Microbiology|March 30, 2022
Tackling the emerging threat of antifungal resistance to human healthMatthew C Fisher, Ana Alastruey-Izquierdo, Judith Berman, et al.
Reproductive Health|December 18, 2020
Association of parity with birthweight and neonatal death in five sites: The Global Network's Maternal Newborn Health Registry studyAna Garces, Wilton Perez, Margo S Harrison, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 1, 2019
Addition of Flucytosine to Fluconazole for the Treatment of Cryptococcal Meningitis in Africa: A Multicountry Cost-effectiveness AnalysisTinevimbo Shiri, Angela Loyse, Lawrence Mwenge, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 1, 2010
Bronchodilator activity of (3R)-3-[[[(3-fluorophenyl)[(3,4,5-trifluorophenyl)methyl]amino] carbonyl]oxy]-1-[2-oxo-2-(2-thienyl)ethyl]-1-azoniabicyclo[2.2.2]octane bromide (CHF5407), a potent, long-acting, and selective muscarinic M3 receptor antagonistG Villetti, F Pastore, M Bergamaschi, et al.
Trials|June 18, 2015
AMBITION-cm: intermittent high dose AmBisome on a high dose fluconazole backbone for cryptococcal meningitis induction therapy in sub-Saharan Africa: study protocol for a randomized controlled trialMooketsi Molefi, Awilly A Chofle, Síle F Molloy, et al.
Plos Biology|December 11, 2020
In silico APC/C substrate discovery reveals cell cycle-dependent degradation of UHRF1 and other chromatin regulatorsJennifer L Franks, Raquel C Martinez-Chacin, Xianxi Wang, et al.
The Journal of Antimicrobial Chemotherapy|November 21, 2022
Population pharmacokinetics of liposomal amphotericin B in adults with HIV-associated cryptococcal meningoencephalitisKatharine E Stott, Melanie Moyo, Ajisa Ahmadu, et al.
Reproductive Health|December 18, 2020
Cesarean birth in the Global Network for Women's and Children's Health Research: trends in utilization, risk factors, and subgroups with high cesarean birth ratesMargo S Harrison, Ana L Garces, Shivaprasad S Goudar, et al.
American Journal of Perinatology|April 3, 2018
Stillbirth, Inflammatory Markers, and Obesity: Results from the Stillbirth Collaborative Research NetworkMargo S Harrison, Vanessa R Thorsten, Donald J Dudley, et al.
Pageof 98